Nordion Inc., a leading provider of products and services to the global health science market, today announced it has signed a five-year contract with Sterigenics International, a global leader in contract sterilization and ionization services, for the supply of Cobalt-60. Under the terms of the agreement, this contract extends until October 31, 2015.
"This contract provides for growth, further demonstrates the attractiveness of this core business, and builds on our global market leadership position," said Steve West, Chief Executive Officer, Nordion. "We continue to drive value for our sterilization customers and the industries they serve through a high quality and reliable supply of isotopes and world-class engineering and logistics capabilities."
For more than 40 years, Cobalt-60 has been a critical component of gamma technology, providing reliable and highly effective sterilization. Gamma sterilization is used for more than 40 per cent of the world's single-use medical supplies and devices each year including bandages, catheters and syringes. This technology is also used for bio-burden reduction in a variety of consumer products including spices, food packaging and cosmetics.
"Nordion and Sterigenics have a successful and long standing history of working together," said Dave Meyer, Chief Executive Officer, Sterigenics. "With Nordion's multi-source capabilities and their solid expertise in manufacturing, engineering, transportation and distribution, we can continue to offer our customers the reliability in service they have come to appreciate and expect."